Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · IEX Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Jul 2, 2024, 4:00 PM
1.040
-0.050 (-4.59%)
After-hours: Jul 2, 2024, 7:57 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $39.65 million as of July 2, 2024. Its market cap has decreased by -37.16% in one year.
Market Cap
39.65M
Enterprise Value
34.92M
1-Year Change
-37.16%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since July 15, 2021, Estrella Immunopharma's market cap has decreased from $52.70M to $39.65M, a decrease of -24.76%. That is a compound annual growth rate of -9.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 39.70M | 1.53% |
| Dec 29, 2023 | 39.10M | -35.05% |
| Dec 30, 2022 | 60.20M | 3.79% |
| Dec 31, 2021 | 58.00M | 10.06% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inotiv | 41.81M |
| Regencell Bioscience Holdings | 41.77M |
| Kezar Life Sciences | 41.50M |
| Protara Therapeutics | 41.49M |
| DURECT | 40.97M |
| Moolec Science | 40.23M |
| Ocuphire Pharma | 40.18M |
| Eyenovia | 40.00M |